Back to search results

Hansoh Pharmaceutical Group Company Limited

hansohpharma.com 8.2

Explore carbon emissions data for Hansoh Pharmaceutical Group Company Limited. Mycelium helps you review reported emissions, disclosure status, Scope 1, Scope 2 and Scope 3 data, climate targets and sustainability information in one company profile.

This profile brings together available carbon emissions data for Hansoh Pharmaceutical Group Company Limited, including reported figures, modelled estimates, disclosure documents and sustainability indicators, so you can review its emissions and compare its performance against similar companies. It is one entry in the Mycelium emissions database. Read how we source and check this data.

Claim this company

Emissions

Total yearly emissions across all scopes

169,375 tCO2e (Location Based)

Scope 1

tCO2e

13,163

Scope 2 (Location Based)

tCO2e

88,227

Scope 3 total

tCO2e

67,984

Checked against pages 60 and 174 of the source report on 3 Oct 2026

Scope 3 reported

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

Something wrong? Contribute to this dataset

See the scope breakdown

Provenance

Review the sources and documents behind Hansoh Pharmaceutical Group Company Limited's emissions data. Provenance matters because it shows where the information comes from, how recent it is and how complete the disclosure appears to be.

Documents

Emissions
Factors

Modelled emission factor Total, all scopes including all Scope 3
0.127 kgCO2e / £

Supplier specific emission factors (kgCO2e / £)

Modelled
Reported
Scope 1 + 2 Direct + purchased energy
0.076
0.076
Upstream + upstream Scope 3
0.125
0.125
Total + all Scope 3
0.127
0.127

Scope 2 in these factors uses the company's location based figure.

Which figure should I use?

Comparing companies? Use Total Modelled. It is the most complete like-for-like view: any categories the company has not disclosed are filled with industry-typical estimates, so a transparent company is not unfairly penalised against one that simply has not reported.

Estimating your own supply-chain emissions from spend with this company? Use Upstream Modelled. The GHG Protocol defines purchased-goods emissions as cradle-to-gate, which means this company's own operations plus its upstream supply chain. The Total figure also includes downstream emissions, such as the lifetime use of the products this company sells, which the GHG Protocol attributes to the users of those products rather than to customers buying goods and services.

Reported counts only emissions the company has filed itself. A blank or low Reported cell does not mean those emissions do not exist, just that the company has not disclosed them. When Reported sits close to Modelled, that is a positive signal: the company has disclosed most of its salient emissions.

Sustainability
Snapshot

Based on reported data, retrieved with AI

  • Hansoh Pharmaceutical Group Company Limited reported 169,375 tCO₂e in 2024.
  • Scope 3 accounted for 40% of emissions.
  • Reported across 15 of 15 GHG Protocol Scope 3 categories.
  • Scope 2 reported under the location based methodology.

According to available emissions disclosures, Hansoh Pharmaceutical Group Company Limited reported total yearly emissions of 169,375 tCO₂e in 2024. Scope 2 emissions accounted for 52% of the footprint, indicating purchased electricity, heating, and cooling consumed across owned operations were the leading contributors to the company's footprint.

The company achieved a Mycelium Score of 8.2, placing it among the leaders in its sector for sustainability performance, and received a transparency score of 100.0, an exceptional result, reflecting open disclosure across nearly every key emissions metric.

Scope
breakdown

Scope 1 emissions

Direct emissions from sources the company owns or controls, such as fuel use, facilities and vehicles.

REPORTED

Direct emissions

13,163

tCO2e

Scope 2 emissions

Indirect emissions from purchased energy, including electricity, heating and cooling.

REPORTED

Location based

88,227

tCO2e

Market based

–

tCO2e

Scope 3 emissions

Wider value chain emissions across the 15 GHG Protocol categories, from purchased goods and business travel to investments, where reported.

REPORTED

Cat 1

Purchased goods & services

11,602

tCO2e
REPORTED

Cat 2

Capital goods

2,239

tCO2e
REPORTED

Cat 3

Fuel & energy related activities

38,671

tCO2e
REPORTED

Cat 4

Upstream transportation & distribution

152

tCO2e
REPORTED

Cat 5

Waste generated in operations

2,522

tCO2e
REPORTED

Cat 6

Business travel

404

tCO2e
REPORTED

Cat 7

Employee commuting

9,885

tCO2e
REPORTED

Cat 8

Upstream leased assets

135

tCO2e
REPORTED

Cat 9

Downstream transportation & distribution

401

tCO2e
REPORTED

Cat 10

Processing of sold products

0

tCO2e
REPORTED

Cat 11

Use of sold products

0

tCO2e
REPORTED

Cat 12

End-of-life treatment of sold products

1,671

tCO2e
REPORTED

Cat 13

Downstream leased assets

287

tCO2e
REPORTED

Cat 14

Franchises

0

tCO2e
REPORTED

Cat 15

Investments

16

tCO2e

Verification

Independent third parties involved in checking or preparing Hansoh Pharmaceutical Group Company Limited's emissions data.

Independent assurance

Independently assured (limited assurance) by China Quality Certification Centre Co., Ltd. (CQC) for 2024

Contact Info

Address

5/F, MANULIFE PLACE
348 KWUN TONG ROAD
KOWLOON
HONG KONG
999077

Country

Hong Kong

Browse carbon emissions data by industry

How scoring works

How the Mycelium Score is calculated

The Mycelium Score is out of 10. Up to 6.5 points reflect carbon intensity vs sector peers (emissions normalised against revenue), scaled by how transparent the reporting is. The band above 6.5 is earned through verified data quality on a claimed profile: declaring every reporting category yourself (up to 2.0), preparation by a carbon accountant (2.0) and independently audited figures (2.0), capped at 10.

A higher score means lower carbon intensity than sector peers, backed by data that's third-party verified, claimed by the company, and fully disclosed. Hansoh Pharmaceutical Group Company Limited's score sits at the top of this page and in the score panel.

How the Transparency Score is calculated

The Transparency Score is the share of a company's estimated footprint that it reported itself, graded from A (very high) down to F (very low). Where a category is missing, Mycelium models what it would hold for a company of that size and industry and counts it as undisclosed, so an unreported category where the bulk of emissions sit hurts far more than a minor one. A Scope 3 total filed without a category breakdown earns very little credit for the part left unattributed, because it does not show which categories are inside it: a company can count business travel, leave purchased goods out entirely, and the total looks the same. Companies with nothing to model are graded on how much of their industry's typical footprint the reported categories cover.

Hansoh Pharmaceutical Group Company Limited has disclosed the emissions categories that are material for its industry, so there's no single bucket dragging the transparency score down. The breakdown above shows full coverage across the categories that matter most for this kind of company.

Cover of Mycelium's scoring methodology white paper Read the full scoring methodology Our white paper covers exactly how the Mycelium Score and Transparency Score are calculated, including the normalisation process and what earns a 10/10. Download the white paper (PDF)

Hansoh Pharmaceutical Group Company Limited carbon emissions FAQs

What are Hansoh Pharmaceutical Group Company Limited's carbon emissions?

In its 2024 reporting year, Hansoh Pharmaceutical Group Company Limited disclosed total emissions of 169,375 tCO2e across all scopes. Scope 2 accounted for the largest share, around 52% of the total.

Does Hansoh Pharmaceutical Group Company Limited report Scope 1, Scope 2 and Scope 3 emissions?

For 2024, Hansoh Pharmaceutical Group Company Limited's available disclosure covers Scope 1 (13,163 tCO2e), Scope 2 (88,227 tCO2e), Scope 3 across 15 of the 15 GHG Protocol categories. Figures not reported by the company are shown as modelled estimates and labelled as such.

How transparent is Hansoh Pharmaceutical Group Company Limited's emissions reporting?

Hansoh Pharmaceutical Group Company Limited has a Mycelium transparency score of 100 out of 100. The score is the share of the company's estimated footprint that it reported itself, so an undisclosed category where most of its emissions sit weighs far more than a minor one.

Is Hansoh Pharmaceutical Group Company Limited sustainable?

Mycelium measures sustainability through carbon emissions data rather than giving a yes or no verdict. Hansoh Pharmaceutical Group Company Limited has a Mycelium Score of 8.2 out of 10, which reflects its emissions intensity against sector peers together with how transparent and well-verified its reporting is. The emissions figures, disclosure documents and climate targets on this page give the fuller picture.

Is Hansoh Pharmaceutical Group Company Limited environmentally friendly?

Carbon emissions are one measurable part of environmental impact, and the part Mycelium tracks. Hansoh Pharmaceutical Group Company Limited disclosed 169,375 tCO2e for 2024, and its Mycelium Score of 8.2 out of 10 shows how that performance compares with similar companies in its sector.

Learn more about our methodology and where this data comes from.